- Home
- SGMO vs BARK Comparison
SGMO vs BARK Comparison
Compare SGMO & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- BARK
- Stock Information
- Founded
- SGMO 1995
- BARK 2011
- Country
- SGMO United States
- BARK United States
- Employees
- SGMO N/A
- BARK N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- BARK Department/Specialty Retail Stores
- Sector
- SGMO Health Care
- BARK Consumer Discretionary
- Exchange
- SGMO Nasdaq
- BARK Nasdaq
- Market Cap
- SGMO 122.8M
- BARK 146.0M
- IPO Year
- SGMO 2000
- BARK N/A
- Fundamental
- Price
- SGMO $0.68
- BARK $0.80
- Analyst Decision
- SGMO Strong Buy
- BARK Strong Buy
- Analyst Count
- SGMO 7
- BARK 3
- Target Price
- SGMO $5.29
- BARK $2.50
- AVG Volume (30 Days)
- SGMO 5.4M
- BARK 740.8K
- Earning Date
- SGMO 11-11-2025
- BARK 11-06-2025
- Dividend Yield
- SGMO N/A
- BARK N/A
- EPS Growth
- SGMO N/A
- BARK N/A
- EPS
- SGMO N/A
- BARK N/A
- Revenue
- SGMO $81,706,000.00
- BARK $470,831,000.00
- Revenue This Year
- SGMO $28.47
- BARK N/A
- Revenue Next Year
- SGMO N/A
- BARK $6.25
- P/E Ratio
- SGMO N/A
- BARK N/A
- Revenue Growth
- SGMO 565.52
- BARK N/A
- 52 Week Low
- SGMO $0.41
- BARK $0.77
- 52 Week High
- SGMO $3.18
- BARK $2.56
- Technical
- Relative Strength Index (RSI)
- SGMO 66.82
- BARK 40.92
- Support Level
- SGMO $0.65
- BARK $0.80
- Resistance Level
- SGMO $0.73
- BARK $0.85
- Average True Range (ATR)
- SGMO 0.06
- BARK 0.03
- MACD
- SGMO 0.02
- BARK -0.00
- Stochastic Oscillator
- SGMO 67.74
- BARK 1.92
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.